Considering that GPR84 has been claimed as a metabolic GPCR, we wanted to evaluate how its expression was regulated in two important metabolic diseases where inflammation plays a key role: diabetes and atherosclerosis (Figure 3). This evidence concerns the gene GPR84 and atherosclerosis.